Loading market data...
Latest Top News
Show more
SEC Concludes Investigation Into Dr. Reddy’s With No Enforcement Action
Dr. Reddy’s Laboratories Ltd has received confirmation from the U.S. Securities and Exchange Commission (SEC) that its investigation into alleged improper payments to healthcare professionals has been concluded with no enforcement action recommended. The probe, initiated in 2020, saw full cooperation from Dr. Reddy’s with SEC, DOJ, and SEBI authorities.
Stay Ahead – Explore Now! Mega Power Push: BHEL Secures ₹130–150 Billion Order in Landmark Deal






